Lexology June 28, 2022
At our recent Health Care AI Law and Policy Summit, Hogan Lovells partner Stuart Langbein moderated a panel discussion on AI policy and reimbursement issues. Joined by representatives from CMS Medicare Administrative Contractor (MAC) Noridian Healthcare Solutions, the AI Healthcare Coalition, Digital Diagnostics, and Tempus, the group’s discussion centered around Medicare’s challenges in providing proper payment to AI innovators within existing reimbursement frameworks. The panel considered issues related to coding, pilot payment programs, Medicaid, ethical guardrails, and the amount of information that regulators should require in medical product submissions for new technologies. We have summarized this discussion below, and the opinions expressed were those of the individuals and not those of their organizations.
AI development seen outpacing reimbursement mechanisms
Teeing...